Continue reading here: Ventyx Biosciences to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Continue reading here: Ventyx Biosciences to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
The rest is here: Viracta Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
View original post here: 89bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Read more: Monthly information related to total number of voting rights and shares composing the share capital - January 31, 2024
Read the original here: Corvus Pharmaceuticals Appoints Jeffrey Arcara as Chief Business Officer
Read the rest here: QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved operational profitability
Here is the original post: Oncternal Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference
Original post: BioSyent Declares First Quarter 2024 Dividend
View original post here: atai Life Sciences Appoints Anne Johnson as Chief Financial Officer
See original here: HUTCHMED Highlights Presentation of Phase III Data on Fruquintinib in Second-Line Gastric Cancer at ASCO Plenary Series Session
Recent Comments